BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 10022998)

  • 1. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
    Nagai N; Oshita T; Murakami J; Ohama K
    Oncol Rep; 1999; 6(2):325-8. PubMed ID: 10022998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection.
    Wang PH; Chen GD; Chang H; Yang SF; Han CP; Lin LY; Ko JL
    Reprod Sci; 2007 May; 14(4):338-48. PubMed ID: 17644806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
    Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
    Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase in (pre)neoplastic cervical disease.
    Wisman GB; De Jong S; Meersma GJ; Helder MN; Hollema H; de Vries EG; Keith WN; van der Zee AG
    Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of telomerase assay for the screening of cervical lesions.
    Kyo S; Takakura M; Ishikawa H; Sasagawa T; Satake S; Tateno M; Inoue M
    Cancer Res; 1997 May; 57(10):1863-7. PubMed ID: 9157976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN.
    Bravaccini S; Amadori A; Scarpi E; Tumedei MM; Zoli W; Silvestrini R
    Anal Cell Pathol (Amst); 2012; 35(5-6):377-80. PubMed ID: 22596181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix.
    Frost M; Bobak JB; Gianani R; Kim N; Weinrich S; Spalding DC; Cass LG; Thompson LC; Enomoto T; Uribe-Lopez D; Shroyer KR
    Am J Clin Pathol; 2000 Nov; 114(5):726-34. PubMed ID: 11068546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preinvasive lesions and their treatment].
    Sidney H; Mage G; Bruhat MA
    Rev Prat; 1990 Jan; 40(1):12-8. PubMed ID: 2300758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of the diagnosis in suspected intraepithelial neoplasia of the cervix.
    Myllynen L; Karjalainen O
    Ann Chir Gynaecol; 1984; 73(1):45-9. PubMed ID: 6732157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Loss of beta 2 microglobulin from the surface of "dysplastic" and malignant epithelial cells of the uterine cervix].
    Tseleni-Balafouta S; Balafoutas AC; Paraskevakou H
    Zentralbl Gynakol; 1989; 111(11):744-8. PubMed ID: 2675495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activation in cervical neoplasia.
    Iwasaka T; Zheng PS; Yokoyama M; Fukuda K; Nakao Y; Sugimori H
    Obstet Gynecol; 1998 Feb; 91(2):260-2. PubMed ID: 9469286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix.
    Shroyer KR; Thompson LC; Enomoto T; Eskens JL; Shroyer AL; McGregor JA
    Am J Clin Pathol; 1998 Feb; 109(2):153-62. PubMed ID: 9583886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma.
    Jarboe EA; Liaw KL; Thompson LC; Heinz DE; Baker PL; McGregor JA; Dunn T; Woods JE; Shroyer KR
    Oncogene; 2002 Jan; 21(4):664-73. PubMed ID: 11850794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA changes in progressive cervical intraepithelial neoplasia.
    Hanselaar AG; Vooijs GP; Mayall BH; Pahlplatz MM; Van't Hof-Grootenboer AE
    Anal Cell Pathol; 1992 Jul; 4(4):315-24. PubMed ID: 1390300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
    Sonoda K; Kaku T; Kamura T; Nakashima M; Watanabe T; Nakano H
    Clin Cancer Res; 1998 Jun; 4(6):1517-20. PubMed ID: 9626471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in cervical intraepithelial neoplasia.
    Wang SZ; Sun JH; Zhang W; Jin SQ; Wang HP; Jin YS; Qu P; Liu Y; Li M
    Chin Med J (Engl); 2004 Feb; 117(2):202-6. PubMed ID: 14975203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local treatment of cervical intraepithelial neoplasia with a 5 percent fluorouracil ointment].
    Barten G
    Zentralbl Gynakol; 1987; 109(24):1510-6. PubMed ID: 3442159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with the Oxford tumour marker in uterine cervical lesions.
    Beltrami CA; Di Loreto C; De Nictolis M; Stramazzotti D
    Appl Pathol; 1984; 2(1):39-42. PubMed ID: 6395880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
    Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
    Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Telomerase activity in cervical carcinoma and cervical intraepithelial neoplasia and its correlation to classification of koilocytosis].
    Leng B; Bian M; Sun A; Fan M; Chen Q
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):262-6. PubMed ID: 11953176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.